We conducted spheroid formation assays, which demonstrated the therapeutic effect of co-targeting STAT3 and AKT to inhibit HIF-1α signaling and decrease tumor growth in combination with cisplatin treatment (Fig. S5). Here, STAT3 is linked to neoplasm.